NFKB1 and Miyoshi myopathy: Two studies by Keats et al. and Annunziata et al. demonstrated that approximately 20% of MM patients and 40% of MM cell lines harbor at least one genetic lesion in MM PC that results in increased or constitutive NFκB pathway activation [4,5].